|
1
|
Gilead Sciences
Foster City,
California
|
$6.6M
|
–
|
–
|
–
|
|
|
2
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$3.31M
|
–
|
–
|
–
|
|
|
3
|
Merck & Co
Rahway,
New Jersey
|
$1.07M
|
–
|
–
|
–
|
|
|
4
|
Takeda Pharmaceutical Company
Tokyo,
Japan
|
$1.07M
|
–
|
–
|
–
|
|
|
5
|
|
$837K
|
+$139K
|
+11,034
|
+15%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$822K
|
+$209K
|
+16,656
|
+26%
|
|
|
7
|
Fidelity Investments
Boston,
Massachusetts
|
$640K
|
-$459K
|
-36,559
|
-37%
|
|
|
8
|
AJU IB Investment Company
Seoul,
South Korea
|
$484K
|
–
|
–
|
–
|
|
|
9
|
Geode Capital Management
Boston,
Massachusetts
|
$275K
|
+$18.5K
|
+1,471
|
+6%
|
|
|
10
|
Balyasny Asset Management
Chicago,
Illinois
|
$184K
|
-$79.8K
|
-6,348
|
-26%
|
|
|
11
|
Trustees of Columbia University in the City of New York
New York
|
$181K
|
–
|
–
|
–
|
|
|
12
|
Renaissance Technologies
New York
|
$129K
|
-$107K
|
-8,494
|
-40%
|
|
|
13
|
UBS Group
Zurich,
Switzerland
|
$118K
|
-$77.5K
|
-6,164
|
-35%
|
|
|
14
|
Avantax Planning Partners
Dubuque,
Iowa
|
$109K
|
+$135K
|
+10,743
|
New
|
|
|
15
|
Two Sigma Investments
New York
|
$60.9K
|
+$65.8K
|
+5,232
|
+677%
|
|
|
16
|
|
$54.1K
|
-$1.24K
|
-99
|
-2%
|
|
|
17
|
Bridgeway Capital Management
Houston,
Texas
|
$51.5K
|
–
|
–
|
–
|
|
|
18
|
Northern Trust
Chicago,
Illinois
|
$48.3K
|
+$24.6K
|
+1,957
|
+70%
|
|
|
19
|
Millennium Management
New York
|
$37K
|
+$45.9K
|
+3,651
|
New
|
|
|
20
|
SevenBridge Financial Group
Harrisburg,
Pennsylvania
|
$33.6K
|
+$4.49K
|
+357
|
+12%
|
|
|
21
|
Aptus Capital Advisors
Fairhope,
Alabama
|
$33.3K
|
+$4.49K
|
+357
|
+12%
|
|
|
22
|
State Street
Boston,
Massachusetts
|
$31.4K
|
–
|
–
|
–
|
|
|
23
|
Scientech Research LLC
Jersey City,
New Jersey
|
$30.8K
|
+$38.2K
|
+3,039
|
New
|
|
|
24
|
ADAR1 Capital Management
Austin,
Texas
|
$29K
|
+$35.9K
|
+2,857
|
New
|
|
|
25
|
Raymond James Financial
St Petersburg,
Florida
|
$24.6K
|
-$14.5K
|
-1,152
|
-32%
|
|
